HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,444 | +79.0% | 60,773 | +70.1% | 0.01% | +100.0% |
| Q2 2023 | $3,041 | -41.1% | 35,721 | -42.7% | 0.00% | -42.9% |
| Q1 2023 | $5,161 | +27.4% | 62,373 | +21.1% | 0.01% | +16.7% |
| Q4 2022 | $4,050 | -99.9% | 51,493 | +2.5% | 0.01% | +20.0% |
| Q3 2022 | $3,718,000 | +14.0% | 50,219 | +0.4% | 0.01% | +25.0% |
| Q2 2022 | $3,260,000 | +6.5% | 50,017 | +3.3% | 0.00% | +33.3% |
| Q1 2022 | $3,060,000 | +19.3% | 48,409 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $2,566,000 | -22.0% | 48,371 | +3.7% | 0.00% | -25.0% |
| Q3 2021 | $3,291,000 | -21.9% | 46,624 | -26.3% | 0.00% | 0.0% |
| Q2 2021 | $4,214,000 | -45.0% | 63,233 | -8.4% | 0.00% | -50.0% |
| Q1 2021 | $7,667,000 | -15.1% | 69,064 | -9.2% | 0.01% | -20.0% |
| Q4 2020 | $9,033,000 | +24.3% | 76,064 | -8.6% | 0.01% | +11.1% |
| Q3 2020 | $7,265,000 | -3.2% | 83,264 | -0.6% | 0.01% | -10.0% |
| Q2 2020 | $7,502,000 | +40.5% | 83,768 | +56.4% | 0.01% | +25.0% |
| Q1 2020 | $5,339,000 | +1.0% | 53,568 | +16.5% | 0.01% | +33.3% |
| Q4 2019 | $5,285,000 | -32.5% | 46,000 | -25.9% | 0.01% | -40.0% |
| Q3 2019 | $7,830,000 | +23.9% | 62,075 | +18.2% | 0.01% | +25.0% |
| Q2 2019 | $6,318,000 | +35.8% | 52,500 | -1.3% | 0.01% | +33.3% |
| Q1 2019 | $4,654,000 | -23.7% | 53,200 | -12.7% | 0.01% | -33.3% |
| Q4 2018 | $6,099,000 | -18.2% | 60,955 | -6.3% | 0.01% | 0.0% |
| Q3 2018 | $7,457,000 | +22.5% | 65,080 | -4.2% | 0.01% | +12.5% |
| Q2 2018 | $6,089,000 | -18.6% | 67,900 | -33.6% | 0.01% | -11.1% |
| Q1 2018 | $7,480,000 | +25.9% | 102,247 | 0.0% | 0.01% | +28.6% |
| Q4 2017 | $5,939,000 | +128.6% | 102,247 | +76.6% | 0.01% | +133.3% |
| Q3 2017 | $2,598,000 | +13.6% | 57,900 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $2,286,000 | -5.5% | 57,900 | -2.9% | 0.00% | 0.0% |
| Q1 2017 | $2,419,000 | +1.5% | 59,628 | +0.6% | 0.00% | 0.0% |
| Q4 2016 | $2,383,000 | +13.9% | 59,269 | +2.6% | 0.00% | 0.0% |
| Q3 2016 | $2,092,000 | +24.9% | 57,769 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $1,675,000 | -17.1% | 57,769 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $2,021,000 | +12.4% | 57,769 | +3.6% | 0.00% | 0.0% |
| Q4 2015 | $1,798,000 | +2.7% | 55,769 | +3.0% | 0.00% | 0.0% |
| Q3 2015 | $1,751,000 | -71.2% | 54,169 | -63.2% | 0.00% | -66.7% |
| Q2 2015 | $6,087,000 | +31.6% | 147,176 | +43.0% | 0.01% | +28.6% |
| Q1 2015 | $4,624,000 | +20.0% | 102,940 | 0.0% | 0.01% | +16.7% |
| Q4 2014 | $3,852,000 | +8.6% | 102,940 | +1.4% | 0.01% | +20.0% |
| Q3 2014 | $3,546,000 | -18.6% | 101,540 | -17.8% | 0.01% | -16.7% |
| Q2 2014 | $4,358,000 | +10.5% | 123,540 | +2.1% | 0.01% | 0.0% |
| Q1 2014 | $3,945,000 | -22.6% | 121,040 | 0.0% | 0.01% | -25.0% |
| Q4 2013 | $5,099,000 | +5.6% | 121,040 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $4,827,000 | -4.7% | 121,040 | -1.2% | 0.01% | -11.1% |
| Q2 2013 | $5,067,000 | – | 122,540 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |